Inclusion Body Myositis: Boundaries That May Define Transition to Treatment Refractoriness

Neurology. 2022 Nov 15;99(20):873-874. doi: 10.1212/WNL.0000000000201506. Epub 2022 Oct 4.

Author

Steven A Greenberg¹

Affiliation

¹ From the Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. sagreenberg@bwh.harvard.edu.

PMID: 36195454
DOI: 10.1212/WNL.0000000000201506

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Muscle, Skeletal
Myositis*
Myositis, Inclusion Body* / diagnosis
Myositis, Inclusion Body* / therapy